Literature DB >> 20034712

2-Butoxyethanol model of haemolysis and disseminated thrombosis in female rats: a preliminary study of the vascular mechanism of osteoarthritis in the temporomandibular joint.

G Amir1, A W Goldfarb, M Nyska, M Redlich, A Nyska, D W Nitzan.   

Abstract

Female rats develop haemolytic anaemia and disseminated thrombosis and infarction in multiple organs, including bone, when exposed to 2-butoxyethanol (BE). There is growing evidence that vascular occlusion of the subchondral bone may play a part in some cases of osteoarthritis. The subchondral bone is the main weight bearer as well as the source of the blood supply to the mandibular articular cartilage. Vascular occlusion is thought to be linked to sclerosis of the subchondral bone associated with disintegration of the articular cartilage. The aim of this study was to find out whether this model of haemolysis and disseminated thrombosis supports the vascular hypothesis of osteoarthritis. Six female rats were given BE orally for 4 consecutive days and the two control rats were given tap water alone. The rats were killed 26 days after the final dose. The mandibular condyles showed histological and radiological features consistent with osteoarthritis in three of the four experimental rats and in neither of the control rats. These results may support the need to explore the vascular mechanism of osteoarthritis further. Copyright Â
© 2009 The British Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20034712     DOI: 10.1016/j.bjoms.2009.11.011

Source DB:  PubMed          Journal:  Br J Oral Maxillofac Surg        ISSN: 0266-4356            Impact factor:   1.651


  1 in total

1.  Rapid conditional targeted ablation model for hemolytic anemia in the rat.

Authors:  Marina M Hanson; Fengming Liu; Shen Dai; Alison Kearns; Xuebin Qin; Elizabeth C Bryda
Journal:  Physiol Genomics       Date:  2016-07-01       Impact factor: 3.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.